PLXPQ — PLx Pharma Winddown Cashflow Statement
0.000.00%
Last trade - 00:00- $0.00m
- -$9.82m
- $8.21m
- 18
- 83
- 11
- 30
Annual cashflow statement for PLx Pharma Winddown, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2017 December 31st | 2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -15.3 | 0.896 | -20.5 | -15.2 | -46.1 |
| Depreciation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 4.92 | -10.8 | 6.81 | 3.04 | 8.38 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -1.99 | 0.249 | 0.871 | -0.2 | 5.51 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -13.3 | -9.5 | -12.7 | -12.2 | -32.1 |
| Capital Expenditures | -0.538 | -0.655 | -0.242 | -0.102 | 0 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 11.8 | 0 | 0.011 | — | 0.095 |
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | 11.2 | -0.655 | -0.23 | -0.102 | 0.095 |
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 26.4 | 0 | 12.6 | 20.8 | 79 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 24.3 | -10.2 | -0.249 | 8.45 | 46.9 |